Promacta Approval Expanded for Children With Chronic ITP

Share this content:
Promacta Approval Expanded for Children With Chronic ITP
Promacta Approval Expanded for Children With Chronic ITP

MONDAY, Aug. 24, 2015 (HealthDay News) -- U.S. Food and Drug Administration approval of the drug Promacta (eltrombopag) has been expanded to include children 1 year and older with chronic immune thrombocytopenic purpura (ITP).

The new approval builds on a recent approval for ages 6 years and up. Promacta has been approved for the disorder among children who have had unsatisfactory results with other drugs, or with surgery to remove the spleen, the agency said in a news release.

Promacta is designed to help increase platelet production, the FDA said. The drug, available in pill or powder form, was clinically evaluated in a trial involving 159 pediatric patients ages 1 to 17. Some 62 percent of those who took Promacta saw an improvement in platelet count, compared with 32 percent among those who took a placebo.

Promacta's most common side effects included upper respiratory infection, diarrhea, abdominal pain, rash, and an increase in liver enzymes. The drug has not been evaluated among children less than a year old, the FDA said.

Promacta is produced by Novartis, based in East Hanover, N.J.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »